WO2003035007A3 - Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 - Google Patents
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 Download PDFInfo
- Publication number
- WO2003035007A3 WO2003035007A3 PCT/US2002/034456 US0234456W WO03035007A3 WO 2003035007 A3 WO2003035007 A3 WO 2003035007A3 US 0234456 W US0234456 W US 0234456W WO 03035007 A3 WO03035007 A3 WO 03035007A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyclooxygenase
- expression
- activity
- compositions exhibiting
- synergistic inhibition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003537576A JP2005506996A (en) | 2001-10-26 | 2002-10-25 | Curcuminoid composition exhibiting synergistic inhibition of cyclooxygenase-2 expression and / or activity |
MXPA04003734A MXPA04003734A (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2. |
EP02784313A EP1446136B1 (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
DE60237836T DE60237836D1 (en) | 2001-10-26 | 2002-10-25 | CURCUMINOID COMPOSITIONS WITH SYNERGISTIC INHIBITION OF EXPRESSION AND / OR EFFECT OF CYCLOOXYGENASE-2 |
CA2464334A CA2464334C (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
NZ532560A NZ532560A (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
KR10-2004-7006048A KR20040054738A (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
DK02784313.5T DK1446136T3 (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions with synergistic inhibition of the expression and / or activity of cyclooxygenase-2 gene |
AT02784313T ATE482696T1 (en) | 2001-10-26 | 2002-10-25 | CUCUMINOID COMPOSITIONS WITH SYNERGISTIC INHIBITION OF THE EXPRESSION AND/OR ACTION OF CYCLOOXYGENASE-2 |
AU2002348096A AU2002348096B2 (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
AU2008202916A AU2008202916B8 (en) | 2001-10-26 | 2008-07-02 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activty of cyclooxygenase-2 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33506201P | 2001-10-26 | 2001-10-26 | |
US60/335,062 | 2001-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003035007A2 WO2003035007A2 (en) | 2003-05-01 |
WO2003035007A3 true WO2003035007A3 (en) | 2003-09-18 |
Family
ID=23310091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/034456 WO2003035007A2 (en) | 2001-10-26 | 2002-10-25 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20030096027A1 (en) |
EP (2) | EP1446136B1 (en) |
JP (3) | JP2005506996A (en) |
KR (1) | KR20040054738A (en) |
AT (1) | ATE482696T1 (en) |
AU (2) | AU2002348096B2 (en) |
CA (1) | CA2464334C (en) |
DE (1) | DE60237836D1 (en) |
DK (1) | DK1446136T3 (en) |
ES (1) | ES2353868T3 (en) |
MX (1) | MXPA04003734A (en) |
NZ (1) | NZ532560A (en) |
PT (1) | PT1446136E (en) |
WO (1) | WO2003035007A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030149113A1 (en) | 2001-10-12 | 2003-08-07 | Caplan Michael J. | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
US20020076452A1 (en) * | 2000-08-01 | 2002-06-20 | Ashni Naturaceuticals, Inc. | Combinations of sesquiterpene lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 |
US7901713B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
US7270835B2 (en) * | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8206753B2 (en) * | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US7815944B2 (en) * | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
US7718198B2 (en) * | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7901714B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
EP1446136B1 (en) * | 2001-10-26 | 2010-09-29 | Metaproteomics, LLC | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
US7279185B2 (en) | 2001-10-26 | 2007-10-09 | Metaproteonics, Llc | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
US20060233902A1 (en) * | 2002-02-14 | 2006-10-19 | Kirin Beer Kabushiki Kaisha | Compositions and foods for improving lipid metabolism |
JP2005529123A (en) * | 2002-04-24 | 2005-09-29 | リサーチ ディベロップメント ファンデーション | Synergistic effect of nuclear transcriptional regulator NF-κB inhibitor and antitumor agent |
EP1523318A4 (en) * | 2002-06-24 | 2007-07-04 | Res Dev Foundation | Treatment of human multiple myeloma by curcumin |
MXPA05004288A (en) * | 2002-10-21 | 2005-08-02 | Metaproteomics Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response. |
JP2005104951A (en) * | 2003-01-17 | 2005-04-21 | Kirin Brewery Co Ltd | Hypotensive composition, blood vessel flexibility-improving composition, and food imparted with such functions |
EP1626731B1 (en) * | 2003-05-22 | 2009-01-21 | Metaproteomics, LLC | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
ITMI20031098A1 (en) * | 2003-05-30 | 2004-11-30 | Indena Spa | USEFUL COMPOUNDS IN ALZHEIMER DISEASE THERAPY AND FORMULATIONS CONTAINING THEM |
US7462646B2 (en) * | 2003-08-26 | 2008-12-09 | Research Development Foundation | Osteoclastogenesis inhibitors and uses thereof |
JP2005154390A (en) * | 2003-11-28 | 2005-06-16 | Morishita Jintan Kk | Hepatoprotectant agent |
AU2011202586B2 (en) * | 2004-02-27 | 2012-03-22 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
US20050192356A1 (en) | 2004-02-27 | 2005-09-01 | Babish John G. | Synergistic anti-inflammatory pharmaceutical compositions and methods of use |
US7914831B2 (en) * | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
AU2005296565A1 (en) * | 2004-10-22 | 2006-04-27 | Kirin Beer Kabushiki Kaisha | Transcriptional factor Nrf2 activator and food having the function of the same imparted thereto |
AU2005304317A1 (en) * | 2004-11-13 | 2006-05-18 | Metaproteomics, Llc | Compositions exhibiting inhibition of cyclooxygenase-2 |
US20080248131A1 (en) * | 2005-08-09 | 2008-10-09 | Metaproteomics, Llc | Protein Kinase Modulation by Hops and Acacia Products |
JP2009518439A (en) * | 2005-12-09 | 2009-05-07 | メタプロテオミクス,エルエルシー | Protein kinase regulation by hops and acacia products |
EP2023747A2 (en) * | 2006-05-24 | 2009-02-18 | DSMIP Assets B.V. | 3,5-dihydroxy-2,4-cyclohexadienones and their derivatives, dietary compositions and fortified food containing them and their uses |
JP2009541326A (en) * | 2006-06-20 | 2009-11-26 | メタプロテオミクス, エルエルシー | Beta acid-based protein kinase-regulated cancer therapy |
US20080051466A1 (en) * | 2006-06-20 | 2008-02-28 | Metaproteomics, Llc | Isoalpha acid based protein kinase modulation cancer treatment |
WO2008048410A2 (en) * | 2006-09-19 | 2008-04-24 | Human Biomolecular Research Institute | Diagnostic methods and genetic markers for alzheimer disease |
MX2009010049A (en) * | 2007-03-19 | 2010-03-04 | Metaproteomics Llc | Methods and compositions for promoting bone and joint health. |
US8192768B2 (en) | 2007-04-03 | 2012-06-05 | Laila Impex | Synergistic anti-inflammatory and antioxidant dietary supplement compositions |
JP2010526882A (en) * | 2007-05-11 | 2010-08-05 | メタプロテオミクス, エルエルシー | Methods and compositions for detoxifying heavy metals |
WO2009066303A2 (en) * | 2007-11-22 | 2009-05-28 | Ganga Raju Gokaraju | New synergistic phytochemical composition for the treatment of obesity |
CA2708613A1 (en) * | 2007-12-10 | 2009-06-18 | Metaproteomics, Llc | Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith |
JP2011516492A (en) * | 2008-04-02 | 2011-05-26 | メタプロテオミクス, エルエルシー | Attenuation of endothelial inflammation and endothelium-monocyte interaction by substituted 1,3-cyclopentadione |
EP2274411A4 (en) * | 2008-04-11 | 2016-01-20 | Betal Llc | Xanthohumol compositions and methods for treating skin diseases or disorders |
WO2013100136A1 (en) | 2011-12-28 | 2013-07-04 | 株式会社マルハニチロ食品 | Degranulation inhibitor containing chlorophyll c |
JP6163084B2 (en) * | 2013-11-11 | 2017-07-12 | キリン株式会社 | Composition for preventing, treating and / or improving cognitive function of dementia, and medicine and food using the same |
JP6242746B2 (en) * | 2014-05-26 | 2017-12-06 | キリン株式会社 | Medicines, foods, and compositions that improve memory learning function |
CN107582962A (en) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | A kind of formula and its extraction process for atrophic gastritis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5494668A (en) * | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
US6143303A (en) * | 1999-08-14 | 2000-11-07 | Janakiram; Chodavarapu | Analgesic anti-inflammatory composition and method of preparing from dodonaea sp |
US6346519B1 (en) * | 1998-09-09 | 2002-02-12 | Advanced Medical Instruments | Method and composition for treating arthritis |
US6391346B1 (en) * | 2001-04-05 | 2002-05-21 | Thomas Newmark | Anti-inflammatory, sleep-promoting herbal composition and method of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07149628A (en) * | 1993-11-30 | 1995-06-13 | Suntory Ltd | Improver for lipid metabolism |
JPH0873369A (en) * | 1994-09-01 | 1996-03-19 | Fuairudo:Kk | Tea for health |
US20010051184A1 (en) * | 1999-05-20 | 2001-12-13 | Madalene C.Y. Heng | Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases |
DE10031955A1 (en) * | 2000-06-30 | 2002-01-17 | Deutsches Krebsforsch | Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing them |
EP1446136B1 (en) * | 2001-10-26 | 2010-09-29 | Metaproteomics, LLC | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
US7914831B2 (en) * | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
-
2002
- 2002-10-25 EP EP02784313A patent/EP1446136B1/en not_active Expired - Lifetime
- 2002-10-25 MX MXPA04003734A patent/MXPA04003734A/en unknown
- 2002-10-25 KR KR10-2004-7006048A patent/KR20040054738A/en not_active Application Discontinuation
- 2002-10-25 AU AU2002348096A patent/AU2002348096B2/en not_active Ceased
- 2002-10-25 PT PT02784313T patent/PT1446136E/en unknown
- 2002-10-25 US US10/282,236 patent/US20030096027A1/en not_active Abandoned
- 2002-10-25 AT AT02784313T patent/ATE482696T1/en active
- 2002-10-25 DE DE60237836T patent/DE60237836D1/en not_active Expired - Lifetime
- 2002-10-25 WO PCT/US2002/034456 patent/WO2003035007A2/en active IP Right Grant
- 2002-10-25 EP EP10008657A patent/EP2253314A3/en not_active Withdrawn
- 2002-10-25 CA CA2464334A patent/CA2464334C/en not_active Expired - Fee Related
- 2002-10-25 JP JP2003537576A patent/JP2005506996A/en not_active Ceased
- 2002-10-25 DK DK02784313.5T patent/DK1446136T3/en active
- 2002-10-25 ES ES02784313T patent/ES2353868T3/en not_active Expired - Lifetime
- 2002-10-25 NZ NZ532560A patent/NZ532560A/en not_active IP Right Cessation
-
2008
- 2008-07-02 AU AU2008202916A patent/AU2008202916B8/en not_active Ceased
-
2010
- 2010-12-27 JP JP2010291333A patent/JP2011093918A/en not_active Withdrawn
- 2010-12-27 JP JP2010291334A patent/JP2011068680A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5494668A (en) * | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
US6346519B1 (en) * | 1998-09-09 | 2002-02-12 | Advanced Medical Instruments | Method and composition for treating arthritis |
US6143303A (en) * | 1999-08-14 | 2000-11-07 | Janakiram; Chodavarapu | Analgesic anti-inflammatory composition and method of preparing from dodonaea sp |
US6391346B1 (en) * | 2001-04-05 | 2002-05-21 | Thomas Newmark | Anti-inflammatory, sleep-promoting herbal composition and method of use |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AU2008202916B2 (en) | 2010-06-03 |
EP2253314A2 (en) | 2010-11-24 |
DK1446136T3 (en) | 2011-01-10 |
NZ532560A (en) | 2005-02-25 |
JP2011093918A (en) | 2011-05-12 |
MXPA04003734A (en) | 2005-06-20 |
PT1446136E (en) | 2010-12-29 |
EP1446136A4 (en) | 2007-01-10 |
EP2253314A3 (en) | 2012-08-01 |
AU2008202916A1 (en) | 2008-07-24 |
CA2464334C (en) | 2012-01-10 |
US20030096027A1 (en) | 2003-05-22 |
AU2002348096B2 (en) | 2008-04-03 |
DE60237836D1 (en) | 2010-11-11 |
WO2003035007A2 (en) | 2003-05-01 |
AU2008202916B8 (en) | 2010-06-10 |
JP2005506996A (en) | 2005-03-10 |
CA2464334A1 (en) | 2003-05-01 |
ATE482696T1 (en) | 2010-10-15 |
KR20040054738A (en) | 2004-06-25 |
EP1446136B1 (en) | 2010-09-29 |
JP2011068680A (en) | 2011-04-07 |
EP1446136A2 (en) | 2004-08-18 |
ES2353868T3 (en) | 2011-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003035007A3 (en) | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 | |
NL350084I2 (en) | Sedaxane and Fludioxonil | |
HUP0303955A2 (en) | Herbicidal compositions comprising benzoylcyclohexanediones and safeners and a method for their use | |
WO2001015680A8 (en) | Composition for treatment of infections of humans and animals | |
NO996269L (en) | Quinoline-indole antimicrobial agents, as well as the use and mixtures thereof | |
NO20080801L (en) | Aerosol formulation for inhalation of beta agonists | |
EP1411959A4 (en) | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 | |
CA2369975A1 (en) | Deodorizing preparations comprising water soluble beta-(1,3)glucans | |
FI963232A0 (en) | Acidified nitrite as an antimicrobial agent | |
HUP0102415A2 (en) | Oxime derivatives, intermediates, preparation thereof and agricultural chemicals containing the same | |
DE60041753D1 (en) | MEDICAMENT FOR THE TREATMENT OF C. PNEUMONIAE INFECTIONS | |
WO2005074986A3 (en) | Bioactive species capable of interfering with a microbial toxin-antitoxin complex and methods for evaluation and use of said bioactive species | |
ATE409065T1 (en) | INHIBITORS OF 17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES | |
CA2271162A1 (en) | Stearidonic acid compositions and uses thereof | |
ES2043671T3 (en) | A COMPOSITION FOR APPLICATION TO A PLANT SITE. | |
WO2002091858A8 (en) | Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods | |
TWI256292B (en) | Reduction inhibitory agent for active oxygen eliminating activity | |
NO20055518L (en) | 5-hydroxyindoles with N-oxide groups, use thereof as phosphodiesterase 4 inhibitor | |
HUP9801881A3 (en) | Hydroximic acid derivatives, preparation and use thereof, pesticide and fungicide compositions containing these compounds as active ingredients | |
WO2004069173A3 (en) | Methods for modulating an inflammatory response | |
WO2002096870A3 (en) | Sponge-derived terpenoids and methods of use | |
WO2003102206A3 (en) | Sgk and nedd used as diagnostic and therapeutic targets | |
BR0309433A (en) | Dry Yeast Composition | |
WO2002069720A3 (en) | Biopesticide compositions | |
FR2379982A1 (en) | COMPOSITION PESTICIDE WITH SYNERGIC EFFECT INCLUDING A PYRETHROID INSECTICIDE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2464334 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/003734 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002348096 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 532560 Country of ref document: NZ Ref document number: 1020047006048 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003537576 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002784313 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002784313 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 532560 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 532560 Country of ref document: NZ |